Altogether, terminally differentiated liver CD8 T cells appeared more primed for T cell immune activity, while tumor CD8 T cells simultaneously exhibited markers of activation, counterbalanced by T cell exhaustion and negative regulation of effector function. The gene discussed is CD8A; the disease is neoplasm.